Inherited genetic variant predisposes to aggressive but not indolent prostate cancer. - Wikidata - awgldk - TriplyDB

Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.

Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.

http://www.wikidata.org/entity/Q33719967

about

Inherited susceptibility for aggressive prostate cancer Genome-wide association study identifies new prostate cancer susceptibility loci A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer.Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality.Prognostic and predictive biomarkers: tools in personalized oncology.Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans Association of prostate-specific antigen doubling time and cancer in men undergoing repeat prostate biopsy.Multiplexed electrochemical protein detection and translation to personalized cancer diagnostics Inherited genetic markers discovered to date are able to identify a significant number of men at considerably elevated risk for prostate cancer Fine-mapping of prostate cancer aggressiveness loci on chromosome 7q22-35.Characterization of SNPs associated with prostate cancer in men of Ashkenazic descent from the set of GWAS identified SNPs: impact of cancer family history and cumulative SNP risk prediction Prostate cancer risk alleles significantly improve disease detection and are associated with aggressive features in patients with a "normal" prostate specific antigen and digital rectal examination Impact of genotyping on outcome of prostatic biopsies: a multicenter prospective study.Genome-wide copy-number variation analysis identifies common genetic variants at 20p13 associated with aggressiveness of prostate cancer.Genome-wide association study of prostate cancer mortality Human polymorphisms at long non-coding RNAs (lncRNAs) and association with prostate cancer risk.Two susceptibility loci identified for prostate cancer aggressiveness.Incorporating Known Genetic Variants Does Not Improve the Accuracy of PSA Testing to Identify High Risk Prostate Cancer on Biopsy.Screening for familial and hereditary prostate cancer.Association of prostate cancer risk with SNPs in regions containing androgen receptor binding sites captured by ChIP-On-chip analyses.Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases.Genetics of asthma susceptibility and severity Evaluating genetic risk for prostate cancer among Japanese and Latinos.HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).Impact of Age at Diagnosis on Outcomes in Men with Castrate-Resistant Prostate Cancer (CRPC).Genome-wide two-locus epistasis scans in prostate cancer using two European populations Whole-exome sequencing of over 4100 men of African ancestry and prostate cancer risk.Using graded response model for the prediction of prostate cancer risk.Utility of genome-wide association study findings: prostate cancer as a translational research paradigm.Association of prostate cancer risk Loci with disease aggressiveness and prostate cancer-specific mortality.Dietary, supplement, and adipose tissue tocopherol levels in relation to prostate cancer aggressiveness among African and European Americans: The North Carolina-Louisiana Prostate Cancer Project (PCaP).Replication study of 34 common SNPs associated with prostate cancer in the Romanian population.Evaluation of reported prostate cancer risk-associated SNPs from genome-wide association studies of various racial populations in Chinese men.The influence of family history on prostate cancer risk: implications for clinical management.Current status of genome-wide association studies in cancer.Prostate cancer genomics, biology, and risk assessment through genome-wide association studies.Molecular genetics of prostate cancer: emerging appreciation of genetic complexity.Nuclear morphometry, nucleomics and prostate cancer progression Genome-wide association studies on prostate cancer: the end or the beginning?

P2860

Q27001297-8A683681-0F83-4757-A229-B67BB69DE1E9 Q28924380-4F481DA4-BB6C-49A8-9940-E58106E3F4CA Q28943269-BE5C2577-1F3F-4E77-8056-3BC415A9CCC3 Q30500998-E2F39419-15FE-4419-A60F-E9FAA491AD73 Q30504100-22F5CED3-2ED7-45CD-9942-C247BD7BCB5B Q33651583-3581217D-FCC2-409D-9E4D-B148E2BE31A7 Q33921139-39A79267-6E40-4D6E-BBF7-C31DE8C8A0AA Q34225923-3A99E6A2-0CB9-4C40-A44D-84A596E72D47 Q34342253-567D51CD-151E-4072-9DFD-EFD39EAE12BB Q34511194-551D5C1A-3B90-40B7-8148-7485D4A253B3 Q34524949-3D3F5B49-A50A-49DC-B67E-B5B259F6A6C3 Q34661857-7E24E22F-D74D-43B9-9D66-9993C4B5FA8E Q34946649-E3BB87AA-2381-4285-AAD4-F401FE95B691 Q35016946-194FC480-4E46-4219-AC06-BA169190C3F6 Q35083552-51ED09FC-9658-45D0-ABE9-DCBFA0FFC7CD Q35399770-663AF944-A4CC-4561-9C59-222419548442 Q35478990-C6CEF1E2-5A92-434D-A1BC-972FEC9084BA Q35575585-FF348717-21DC-4529-B4C3-74EF935D3F41 Q35796865-91E0B8E2-315F-486B-8A98-1A362FAD32DD Q35861576-4DE6F02D-4724-41A5-BA41-E2B72DCF731A Q36005195-795AC7E4-C057-470E-AD90-4C249A3D642F Q36100579-1CFAB579-51CF-4364-B5F3-076DE7E240E0 Q36201283-4AAD7A7F-F28A-40BD-A378-AAF0522F507F Q36388749-B862ECEC-03DF-4020-BE9F-ED7AF4B790D8 Q36503369-16B39B7A-F34C-4F34-8766-588E38FDC131 Q36746831-4BB35BC4-F95A-472F-8A8B-F66C59A9FAF6 Q36790692-9E840E54-8B2F-4B84-81C5-2E033F7E6038 Q36895709-9EE52351-6A52-4D9B-AE99-1181B0ABB018 Q37074047-C2AAB3F5-8492-48BF-9EC9-D514AECC2086 Q37122541-ACC272F0-D39A-4D66-9700-4D5648A31740 Q37262639-BFA5AA51-7800-4184-8FC0-0189573D0C8D Q37354516-4C1F58E8-9AB6-41AB-BCC8-86E95A07D969 Q37447848-80FE8063-7AC8-4B89-9473-95F7367FD682 Q37592171-A74767FD-BBF3-406F-8301-26A0E57343CC Q37821956-4308505E-73FE-4518-A2D8-779746401934 Q37890286-3DA7B137-8316-4AC3-9768-EBF3B3F5411E Q37969803-69FE75A4-2C47-4858-9AD3-122F8DEFE173 Q37972706-DD8CD635-62C5-4B58-B0C1-DE1A97BD773E Q38002780-DF5836D5-63E8-4736-8860-E0154A3A6ED3 Q38132063-E62964D9-AB89-4169-8D3B-BB5A0F74BABB

P2860

Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.

http://www.wikidata.org/entity/Q33719967

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.

@ast

Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.

@en

type

label

Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.

@ast

Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.

@en

prefLabel

Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.

@ast

Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.

@en

P1433

Q33719967-C6DD7E7E-5873-46DB-9079-F4903D67E3FC

P1476

Q33719967-7B6036D9-FDE4-4FC8-A83A-AF7B47FA42FF

P2093

Q33719967-12AB46C4-CB33-462B-97B3-BAA2A5B560FC

Q33719967-14AB09BE-269E-4E1C-89A7-A7FF8EF3211A

Q33719967-151F4CF4-5F06-44F6-AE57-2F9F0793C25B

Q33719967-17DC1384-6807-459B-9C40-D495767A7E6F

Q33719967-189B6D9D-8F0F-4F81-A556-71677BEAF196

Q33719967-199EFCA3-0D40-4605-9CA1-75D03271EAA0

Q33719967-3537B140-8403-46E9-BE29-9FBE996CAA8F

Q33719967-3E3945C5-23CD-4AEC-98DC-D02EF92B38E2

Q33719967-5BF9F480-3696-426D-970B-9DFB76B10DAC

Q33719967-61E1A51C-B483-43DF-972A-974F354AEA8F

P2860

Q33719967-03E54FEA-8B72-4F89-BCBB-B59FAB351AC1

Q33719967-09160773-8279-4452-BDC2-40FC1CCA3062

Q33719967-0B3E5CEF-84A6-45E7-9E06-4CB90FEAE095

Q33719967-11AC69C1-E2DE-40C4-A819-D69BDCDE7E2A

Q33719967-15B0C813-E362-48A2-B823-69E869811971

Q33719967-178266AC-18CC-4CC6-BBBE-EF4166B20EAD

Q33719967-2CB6A518-C21B-41B3-867F-66F613A796BE

Q33719967-2EB8B759-2744-438C-9BE4-A8F9F307A6BD

Q33719967-35002A48-366E-41E4-91C7-45FDC3F416AE

Q33719967-3923F0C8-42B2-440F-91EE-081FC3E21D8E

P304

Q33719967-F96F7EAB-EB14-48F8-A9CB-566D62739D78

P31

Q33719967-F7D3F274-9845-4FA2-B66B-9E37B57FB631

P356

Q33719967-6CC29E7B-0F3F-4DBE-8211-31C3BAE7CB5C

P433

Q33719967-AC9D9CB6-8906-4FE8-BE41-C991A76C22A6

P478

Q33719967-2C3A40F2-901E-4397-9B2A-34B223F50A74

P50

Q33719967-00C94C77-5599-499E-8DCF-4B9BF4266049

Q33719967-219A6416-92CE-479A-8897-40A8CD01E89F

Q33719967-889C6E68-A612-4705-B1C8-6195CFEFF770

P577

Q33719967-355FC911-89EF-4451-BE08-55B6F1340B1C

P5875

Q33719967-A6D3DE1F-851D-40D8-A5DE-3CAAE234771E

P698

Q33719967-860EC53C-B9C0-481E-82F8-05AE8F9D10A0

P932

Q33719967-5ABDD6FF-14EA-41B0-97F6-3F5F4D08FBBC

P356

PNAS.0914061107

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.

@en

P2093

A Karim Kader

http://www.w3.org/2001/XMLSchema#string

David Duggan

http://www.w3.org/2001/XMLSchema#string

Fang-Chi Hsu

http://www.w3.org/2001/XMLSchema#string

Fredrik Wiklund

http://www.w3.org/2001/XMLSchema#string

Ge Li

http://www.w3.org/2001/XMLSchema#string

Jeffrey M Trent

http://www.w3.org/2001/XMLSchema#string

Jielin Sun

http://www.w3.org/2001/XMLSchema#string

John Carpten

http://www.w3.org/2001/XMLSchema#string

Jonas Hugosson

http://www.w3.org/2001/XMLSchema#string

Kathleen E Wiley

http://www.w3.org/2001/XMLSchema#string

P2860

Mortality results from a randomized prostate-cancer screening trial

Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis

Multiple newly identified loci associated with prostate cancer susceptibility

Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer

Multiple loci identified in a genome-wide association study of prostate cancer

Identification of seven new prostate cancer susceptibility loci through a genome-wide association study

Cancer statistics, 2009

Genome-wide association study of prostate cancer identifies a second risk locus at 8q24

Screening and prostate-cancer mortality in a randomized European study

Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium.

P304

2136-2140

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0914061107

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

Henrik Grönberg

P577

2010-01-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41040317

http://www.w3.org/2001/XMLSchema#string

P698

20080650

http://www.w3.org/2001/XMLSchema#string

P932

2836698

http://www.w3.org/2001/XMLSchema#string